Research Article
Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea
Table 5
Multidrug resistance of gram-negative and gram-positive isolates from vaginal discharge.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
R1: single drug resistance; R2: double drug resistance; R3-R9: multidrug resistance; Amp: ampicillin; GEN: gentamicin; COT: co-trimoxazole; ERY: erythromycin; AMK: amikacin; CAZ: ceftazidime; PEN: penicillin; TET: tetracycline; SXT: trimethoprim-sulfamethoxazole; NAL: nalidixic acid; CIP: ciprofloxacin; CHL: chloramphenicol; CL: cephalexin; CRO: ceftriaxone; F: nitrofurantoin; CD: clindamycin; ox: oxacillin; Rif: rifampicin; Van: vancomycin. |